Brontictuzumab (Synonyms: OMP 52M51; Anti-Human NOTCH1 Recombinant Antibody) |
| Catalog No.GC68809 |
Brontictuzumab (OMP 52M51) es un anticuerpo monoclonal (MAb) que puede inhibir la señalización de Notch1. Brontictuzumab se une selectivamente a la región de control negativo de Notch1. Brontictuzumab puede inhibir la proliferación celular tumoral. Brontictuzumab se utiliza en investigaciones sobre leucemia y linfoma.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1447814-75-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Brontictuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Brontictuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *